Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for... Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema. 더 보기
-- Navenibart Demonstrated 6 Months of HAE Attack Prevention with 1 or 2 Doses -- -- 90-95% Mean Monthly Attack Rate Reduction Supporting Chronic Dosing 2 or 4 Times Per Year -- -- 67...
Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, granted stock options to purchase 32,500...
-- Navenibart (STAR-0215), the Potential Market-Leading Therapy for the Treatment of Hereditary Angioedema, on Track for Expected Phase 3 Initiation in Q1 2025 -- -- Final 3- and 6-Month Results...
Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, today announced that Jill C. Milne...
기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.545 | -5.39871223378 | 10.095 | 11.01 | 9.4 | 369164 | 10.08639933 | CS |
4 | 0.69 | 7.78781038375 | 8.86 | 11.01 | 8.68 | 347930 | 9.97806118 | CS |
12 | -2.87 | -23.1078904992 | 12.42 | 12.72 | 8.61 | 311518 | 10.79237331 | CS |
26 | 0.45 | 4.94505494505 | 9.1 | 12.92 | 8.61 | 349518 | 10.76020019 | CS |
52 | 3.23 | 51.1075949367 | 6.32 | 16.9 | 5.84 | 605341 | 11.33092776 | CS |
156 | 4.23 | 79.5112781955 | 5.32 | 16.9 | 2.36 | 312855 | 10.47523637 | CS |
260 | 1.02 | 11.9577960141 | 8.53 | 16.9 | 2.36 | 291556 | 10.4243443 | CS |
귀하가 조회한 주식이 이 박스에 나타나며 쉽게 최근 시세로 돌아갈 수 있습니다.
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관